Identifying high-efficiency α-glucosidase inhibitors from Abelmoschus manihot (L.) Medik.: A quadrant-based integration of in vitro potency and in silico analysis
Journal of Pharmacy & Pharmacognosy Research · 01.03.2026 · 14 (2) · 2272
DOI: 10.56499/jppres_14.2.2272 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy & Pharmacognosy Research, online erschienen am 01.03.2026. Verfasst von Juliet Tangka und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Context: α-Glucosidase represents one of the key treatments for diabetes based on its ability to regulate postprandial blood glucose levels.
Aims
To evaluate the α-glucosidase inhibitory potential of Abelmoschus manihot (L.) Medik, an endemic species of Minahasa, Indonesia, which is consumed as a vegetable and has been used as an anti-diabetic herbal medicine.
Methods
The α-glucosidase inhibitory activity of A. manihot ethanolic extract was benchmarked against acarbose in vitro. A multi-parametric quadrant analysis was applied to 27 identified phytochemicals to rank them based on binding affinity (ΔG) and ligand efficiency (LE). Top-ranked leads (stigmasterol and hibiscone-B) underwent 100 ns molecular dynamics (MD) simulations and MM-PBSA calculations to validate binding stability and energetic profiles.
Results
The extract demonstrated robust, dose-dependent inhibition (IC50 = 1069.71 µg/mL) and achieved superior maximal efficacy (92.0%) compared to acarbose. Quadrant analysis identified stigmasterol as a "Power Binder" (ΔG = -9.17 kcal/mol) and hibiscone-B as a "Precision Lead" (LE = -0.43), both of which outperformed acarbose in atomic binding efficiency. MD simulations confirmed that hibiscone-B maintains a stable occupancy of the catalytic cleft, supported by persistent hydrogen bonds with ASP203 and ASP542.
Conclusions
A. manihot serves as a potent botanical matrix for anti-diabetic leads. The narrow 3.5-fold potency gap between the crude extract and its pure lead, hibiscone-B, underscores the high efficiency of its phytochemical components, offering a superior alternative to traditional carbohydrate-mimetic inhibitors. Hibiscone-B and stigmasterol are identified as high-priority templates for the development of next-generation inhibitors.
Zitieren
APA
Tangka, J., Dumanauw, J. M., Nurdiana, N., Salam, R., & Lyrawati, D. (2026). Identifying high-efficiency α-glucosidase inhibitors from Abelmoschus manihot (L.) Medik.: A quadrant-based integration of in vitro potency and in silico analysis. Journal of Pharmacy & Pharmacognosy Research, 14(2), 2272. https://doi.org/10.56499/jppres_14.2.2272
Vancouver
Tangka J, Dumanauw JM, Nurdiana N, Salam R, Lyrawati D. Identifying high-efficiency α-glucosidase inhibitors from Abelmoschus manihot (L.) Medik.: A quadrant-based integration of in vitro potency and in silico analysis. Journal of Pharmacy & Pharmacognosy Research. 2026;14(2):2272. doi:10.56499/jppres_14.2.2272
BibTeX
@article{Tangka2026,
author = {Tangka, Juliet and Dumanauw, Jovie M. and Nurdiana, Nurdiana and Salam, Rudy and Lyrawati, Diana},
title = {Identifying high-efficiency α-glucosidase inhibitors from Abelmoschus manihot (L.) Medik.: A quadrant-based integration of in vitro potency and in silico analysis},
journal = {Journal of Pharmacy & Pharmacognosy Research},
year = {2026},
volume = {14},
number = {2},
pages = {2272},
doi = {10.56499/jppres_14.2.2272}
}
EUVIMED